UK markets open in 6 hours 54 minutes

Novozymes A/S (NVZMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
73.09+0.34 (+0.47%)
At close: 10:43AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
14,233,000
14,012,000
14,374,000
14,390,000
14,531,000
Cost of revenue
6,100,000
6,159,000
6,420,000
6,135,000
6,118,000
Gross profit
8,133,000
7,853,000
7,954,000
8,255,000
8,413,000
Operating expenses
Research development
2,069,000
1,937,000
1,966,000
1,865,000
1,913,000
Selling general and administrative
2,418,000
2,320,000
2,469,000
2,363,000
2,450,000
Total operating expenses
4,378,000
4,243,000
4,409,000
4,185,000
4,300,000
Operating income or loss
3,755,000
3,610,000
3,545,000
4,070,000
4,113,000
Interest expense
60,000
63,000
86,000
13,000
27,000
Income before tax
3,793,000
3,521,000
3,799,000
3,936,000
3,876,000
Income tax expense
749,000
695,000
644,000
709,000
756,000
Income from continuing operations
3,044,000
2,826,000
3,155,000
3,227,000
3,120,000
Net income
3,044,000
2,825,000
3,154,000
3,226,000
3,119,000
Net income available to common shareholders
3,044,000
2,825,000
3,154,000
3,226,000
3,119,000
Basic EPS
-
10.07
11.06
11.11
10.56
Diluted EPS
-
10.02
11.01
11.03
10.49
Basic average shares
-
280,428
285,110
290,422
295,339
Diluted average shares
-
282,023
286,551
292,362
297,202
EBITDA
-
4,850,000
5,067,000
4,960,000
4,943,000